Martinez-Moreno C, Calderon-Vallejo D, Diaz-Galindo C, Hernandez-Jasso I, Olivares-Hernandez J, Avila-Mendoza J
Sci Rep. 2024; 14(1):26420.
PMID: 39488642
PMC: 11531546.
DOI: 10.1038/s41598-024-78073-3.
Chucair-Elliott A, Ocanas S, Pham K, Machalinski A, Plafker S, Stout M
Neurobiol Aging. 2024; 140():41-59.
PMID: 38723422
PMC: 11173338.
DOI: 10.1016/j.neurobiolaging.2024.04.012.
Yang Z, Yan L, Zhang W, Qi J, An W, Yao K
Front Neurosci. 2024; 18:1265630.
PMID: 38298913
PMC: 10828017.
DOI: 10.3389/fnins.2024.1265630.
Xin J, Zhou L, Zhang L, Guo K, Yang D
Cell Transplant. 2023; 32:9636897231213309.
PMID: 38018498
PMC: 10687918.
DOI: 10.1177/09636897231213309.
Otsuka M, Arai K, Yoshida T, Hayashi A
Graefes Arch Clin Exp Ophthalmol. 2023; 262(3):823-833.
PMID: 37851131
DOI: 10.1007/s00417-023-06262-3.
Critical Role of VEGF as a Direct Regulator of Photoreceptor Function.
Hu J, Zhu M, Li D, Wu Q, Le Y
Adv Exp Med Biol. 2023; 1415:487-491.
PMID: 37440076
DOI: 10.1007/978-3-031-27681-1_71.
Use of gene therapy for optic nerve protection: Current concepts.
Xu K, Yu L, Wang Z, Lin P, Zhang N, Xing Y
Front Neurosci. 2023; 17:1158030.
PMID: 37090805
PMC: 10117674.
DOI: 10.3389/fnins.2023.1158030.
Neuroprotective effect of the calcium channel blocker nilvadipine on retinal ganglion cell death in a mouse ocular hypertension model.
Tsuruga H, Murata H, Araie M, Aihara M
Heliyon. 2023; 9(3):e13812.
PMID: 36879972
PMC: 9984798.
DOI: 10.1016/j.heliyon.2023.e13812.
Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development.
Wu K, Kulbay M, Toameh D, Xu A, Kalevar A, Tran S
Pharmaceutics. 2023; 15(2).
PMID: 36840007
PMC: 9963330.
DOI: 10.3390/pharmaceutics15020685.
Expression of the neuroprotective factors BDNF, CNTF, and FGF-2 in normal and oxygen induced retinopathy.
Xin J, He Y, Guo K, Yang D
Front Neurosci. 2022; 16:971952.
PMID: 36532277
PMC: 9755753.
DOI: 10.3389/fnins.2022.971952.
Ciliary neurotrophic factor-mediated neuroprotection involves enhanced glycolysis and anabolism in degenerating mouse retinas.
Rhee K, Wang Y, Hoeve J, Stiles L, Nguyen T, Zhang X
Nat Commun. 2022; 13(1):7037.
PMID: 36396639
PMC: 9672129.
DOI: 10.1038/s41467-022-34443-x.
Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report.
Ameen Ismail A, Sadek S, Hatata R
BMC Ophthalmol. 2022; 22(1):434.
PMID: 36376841
PMC: 9664730.
DOI: 10.1186/s12886-022-02657-8.
Macular Telangiectasia Type 2: A Comprehensive Review.
Kedarisetti K, Narayanan R, Stewart M, Reddy Gurram N, Khanani A
Clin Ophthalmol. 2022; 16:3297-3309.
PMID: 36237488
PMC: 9553319.
DOI: 10.2147/OPTH.S373538.
Patterns of NFkB activation resulting from damage, reactive microglia, cytokines, and growth factors in the mouse retina.
Palazzo I, Kelly L, Koenig L, Fischer A
Exp Neurol. 2022; 359:114233.
PMID: 36174748
PMC: 9722628.
DOI: 10.1016/j.expneurol.2022.114233.
Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas.
Norte-Munoz M, Gallego-Ortega A, Lucas-Ruiz F, Gonzalez-Riquelme M, Changa-Espinoza Y, Galindo-Romero C
Stem Cell Res Ther. 2022; 13(1):430.
PMID: 35987845
PMC: 9392272.
DOI: 10.1186/s13287-022-03129-y.
Regulations of Retinal Inflammation: Focusing on Müller Glia.
Chen Y, Xia Q, Zeng Y, Zhang Y, Zhang M
Front Cell Dev Biol. 2022; 10:898652.
PMID: 35573676
PMC: 9091449.
DOI: 10.3389/fcell.2022.898652.
Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies.
Liu W, Liu S, Li P, Yao K
Int J Mol Sci. 2022; 23(9).
PMID: 35563274
PMC: 9101511.
DOI: 10.3390/ijms23094883.
The Role of Interleukin-6 Family Members in Cardiovascular Diseases.
Feng Y, Ye D, Wang Z, Pan H, Lu X, Wang M
Front Cardiovasc Med. 2022; 9:818890.
PMID: 35402550
PMC: 8983865.
DOI: 10.3389/fcvm.2022.818890.
Shaping the Microglia in Retinal Degenerative Diseases Using Stem Cell Therapy: Practice and Prospects.
Jin N, Sha W, Gao L
Front Cell Dev Biol. 2021; 9:741368.
PMID: 34966736
PMC: 8710684.
DOI: 10.3389/fcell.2021.741368.
The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease.
Martinez Velazquez L, Ballios B
Int J Mol Sci. 2021; 22(21).
PMID: 34768969
PMC: 8583900.
DOI: 10.3390/ijms222111542.